Free Trial

Maravai LifeSciences (MRVI) Competitors

Maravai LifeSciences logo
$2.76 0.00 (0.00%)
Closing price 07/9/2025 04:00 PM Eastern
Extended Trading
$2.71 -0.05 (-1.81%)
As of 07/9/2025 06:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MRVI vs. XENE, GMTX, IBRX, TWST, ARWR, APLS, VCEL, RXRX, NAMS, and DNLI

Should you be buying Maravai LifeSciences stock or one of its competitors? The main competitors of Maravai LifeSciences include Xenon Pharmaceuticals (XENE), Gemini Therapeutics (GMTX), ImmunityBio (IBRX), Twist Bioscience (TWST), Arrowhead Pharmaceuticals (ARWR), Apellis Pharmaceuticals (APLS), Vericel (VCEL), Recursion Pharmaceuticals (RXRX), NewAmsterdam Pharma (NAMS), and Denali Therapeutics (DNLI). These companies are all part of the "pharmaceutical products" industry.

Maravai LifeSciences vs. Its Competitors

Maravai LifeSciences (NASDAQ:MRVI) and Xenon Pharmaceuticals (NASDAQ:XENE) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, risk, dividends, media sentiment, valuation and profitability.

In the previous week, Maravai LifeSciences had 3 more articles in the media than Xenon Pharmaceuticals. MarketBeat recorded 7 mentions for Maravai LifeSciences and 4 mentions for Xenon Pharmaceuticals. Xenon Pharmaceuticals' average media sentiment score of 0.30 beat Maravai LifeSciences' score of 0.26 indicating that Xenon Pharmaceuticals is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Maravai LifeSciences
2 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Xenon Pharmaceuticals
0 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Maravai LifeSciences has a beta of 0.28, meaning that its stock price is 72% less volatile than the S&P 500. Comparatively, Xenon Pharmaceuticals has a beta of 1.1, meaning that its stock price is 10% more volatile than the S&P 500.

50.3% of Maravai LifeSciences shares are held by institutional investors. Comparatively, 95.5% of Xenon Pharmaceuticals shares are held by institutional investors. 2.1% of Maravai LifeSciences shares are held by insiders. Comparatively, 5.5% of Xenon Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Maravai LifeSciences has higher revenue and earnings than Xenon Pharmaceuticals. Xenon Pharmaceuticals is trading at a lower price-to-earnings ratio than Maravai LifeSciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Maravai LifeSciences$259.18M2.71-$144.85M-$1.14-2.42
Xenon Pharmaceuticals$9.43M265.91-$234.33M-$3.23-10.12

Maravai LifeSciences currently has a consensus price target of $6.64, suggesting a potential upside of 140.54%. Xenon Pharmaceuticals has a consensus price target of $54.82, suggesting a potential upside of 67.74%. Given Maravai LifeSciences' higher possible upside, analysts plainly believe Maravai LifeSciences is more favorable than Xenon Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Maravai LifeSciences
1 Sell rating(s)
7 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.25
Xenon Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
12 Buy rating(s)
0 Strong Buy rating(s)
3.00

Xenon Pharmaceuticals has a net margin of 0.00% compared to Maravai LifeSciences' net margin of -67.14%. Maravai LifeSciences' return on equity of -12.91% beat Xenon Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Maravai LifeSciences-67.14% -12.91% -6.87%
Xenon Pharmaceuticals N/A -32.44%-30.84%

Summary

Maravai LifeSciences and Xenon Pharmaceuticals tied by winning 8 of the 16 factors compared between the two stocks.

Get Maravai LifeSciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for MRVI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MRVI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MRVI vs. The Competition

MetricMaravai LifeSciencesMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$702.86M$10.41B$5.51B$8.95B
Dividend YieldN/A2.08%5.25%4.02%
P/E Ratio-2.4216.4028.0520.16
Price / Sales2.7131.09440.05188.47
Price / Cash4.4722.7937.0657.97
Price / Book1.213.728.125.62
Net Income-$144.85M$235.43M$3.16B$248.50M
7 Day Performance-0.33%2.31%3.15%4.49%
1 Month Performance27.78%2.59%3.49%7.03%
1 Year Performance-64.25%-10.94%34.06%21.07%

Maravai LifeSciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MRVI
Maravai LifeSciences
3.7009 of 5 stars
$2.76
flat
$6.64
+140.5%
-63.5%$702.86M$259.18M-2.42610News Coverage
XENE
Xenon Pharmaceuticals
2.9077 of 5 stars
$31.30
-3.4%
$54.82
+75.1%
-16.7%$2.40B$7.50M-9.69210News Coverage
Options Volume
GMTX
Gemini Therapeutics
N/A$54.50
+0.7%
N/A+12.8%$2.36BN/A-54.5030High Trading Volume
IBRX
ImmunityBio
2.2489 of 5 stars
$2.64
-2.2%
$12.25
+364.0%
-57.1%$2.33B$14.74M-4.55590Analyst Forecast
TWST
Twist Bioscience
4.3275 of 5 stars
$36.79
+2.4%
$50.40
+37.0%
-22.5%$2.20B$312.97M-11.32990
ARWR
Arrowhead Pharmaceuticals
3.7268 of 5 stars
$15.80
-1.7%
$43.71
+176.7%
-25.5%$2.18B$3.55M-11.29400
APLS
Apellis Pharmaceuticals
4.4132 of 5 stars
$17.31
-0.7%
$40.05
+131.4%
-48.8%$2.18B$781.37M-9.67770
VCEL
Vericel
2.9392 of 5 stars
$42.55
+2.0%
$61.14
+43.7%
-9.9%$2.14B$237.22M1,418.81300
RXRX
Recursion Pharmaceuticals
1.9449 of 5 stars
$5.06
+0.6%
$7.00
+38.3%
-24.9%$2.06B$58.84M-2.86400Trending News
Analyst Forecast
Options Volume
NAMS
NewAmsterdam Pharma
2.2834 of 5 stars
$18.11
-2.5%
$42.89
+136.8%
+8.2%$2.03B$45.56M-9.634
DNLI
Denali Therapeutics
4.6543 of 5 stars
$13.99
-0.8%
$33.71
+141.0%
-28.4%$2.03BN/A-5.24430News Coverage
Analyst Revision

Related Companies and Tools


This page (NASDAQ:MRVI) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners